Briefly, elevated MIF expression was significantly associated with tumor stage (p < 0.0001), lymph node metastasis (p = 0.0002), distant metastasis (p = 0.0175) and the survival rate of patients (p = 0.0447) but not with other clinicopathological parameters, including age and sex (Table 1). This evidence concerns the gene MIF and metastasis.